Dr. Reddy's Laboratories Limited
RDY NYSEHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Jul 21, 2026
ET
EPS Est.
0.09
EPS Actual
0.06
Revenue Est.
$850.6M
Revenue Actual
$835.7M
Next Earnings Report
Date
Oct 23, 2026 · Fri
ET Oct 23, 2026 · Fri
Time
10/23 10:00-13:30
Pre-market(ET)
Fiscal Period
FY2027 Q2
EPS Est.
0.10
Revenue Est.
$880.4M
Company Overview
Dr. Reddy's Laboratories Limited (ticker RDY) is listed on NYSE with a market cap of about $10.2B. Its next earnings report (FY2027 Q2) is expected on Oct 23, 2026 (ET), Pre-market, with consensus EPS of 0.10. In the last 15 reported quarters, EPS beat consensus estimates 11 times.
Actual EPS TrendRecently15Term · Jan 25, 2023 → Jul 21, 2026
Jan 25, 2023Range: 0.04 ~ 0.22Jul 21, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 21, 2026 | -- | 0.09 | Below forecast↓0.06 | $850.6M | $835.7M |
| May 11, 2026 | -- | 0.09 | Below forecast↓0.06 | $886.6M | $785.9M |
| Jan 20, 2026 | -- | 0.16 | 0.16 | $927.7M | $951.6M |
| Oct 24, 2025 | -- | 0.18 | Above forecast↑0.19 | $979.8M | $1B |
| Jul 23, 2025 | -- | 0.18 | Above forecast↑0.20 | $1.01B | $988.9M |
| May 9, 2025 | -- | 0.20 | Above forecast↑0.22 | $978.2M | $996.2M |
| Jan 29, 2025 | -- | 0.19 | Above forecast↑0.20 | $975.7M | $969.6M |
| Nov 5, 2024 | -- | 0.21 | Below forecast↓0.04 | $909.2M | $954.3M |
| Jul 27, 2024 | -- | 0.19 | Above forecast↑0.20 | $869.8M | $920.7M |
| May 7, 2024 | -- | 0.17 | Above forecast↑0.19 | $847.6M | $848.1M |
| Jan 31, 2024 | -- | 0.17 | Above forecast↑0.20 | $833.4M | $868M |
| Oct 27, 2023 | -- | 0.18 | Above forecast↑0.21 | $816.2M | $826.4M |
| Jul 26, 2023 | -- | 0.14 | Above forecast↑0.21 | $777.8M | $822.4M |
| May 10, 2023 | -- | 0.11 | Above forecast↑0.14 | $745.2M | $767M |
| Jan 25, 2023 | -- | 0.12 | Above forecast↑0.18 | $729.1M | $829.8M |
Original Filings (SEC)
Earnings Release6-K · 2026-07-23 ↗
Earnings Release6-K · 2026-07-23 ↗
Earnings Release6-K · 2026-07-23 ↗
Earnings Release6-K · 2026-07-23 ↗
Earnings Release6-K · 2026-07-23 ↗
Earnings Release6-K · 2026-07-22 ↗
Earnings Release6-K · 2026-07-22 ↗
Earnings Release6-K · 2026-07-22 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
